Clinical Trials Logo

Clinical Trial Summary

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02896101
Study type Interventional
Source Glenmark Pharmaceuticals Ltd. India
Contact
Status Completed
Phase Phase 3
Start date August 2016
Completion date June 2017

See also
  Status Clinical Trial Phase
Completed NCT02595073 - Clinical Study to Evaluate the Efficacy and Safety of DSXS With Atopic Dermatitis Phase 3
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Enrolling by invitation NCT03654755 - Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis Phase 2
Not yet recruiting NCT03632174 - Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis N/A
Not yet recruiting NCT03441568 - In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control N/A
Not yet recruiting NCT03661138 - A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis Phase 3
Completed NCT03304470 - A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis Phase 2
Not yet recruiting NCT03684343 - Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age N/A
Recruiting NCT03051347 - Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments N/A
Recruiting NCT02910791 - The Role of Bacterial Toxins in Human Skin Disease N/A
Completed NCT02865356 - Topical Solution for the Treatment of Atopic Dermatitis Phase 2
Completed NCT02914548 - Study of OPA-15406 Ointment in Patients With Atopic Dermatitis Phase 2
Completed NCT02844452 - Antipruritic Effect of Acupuncture in Patients With Atopic Dermatitis N/A
Completed NCT02260986 - Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis Phase 3
Completed NCT01927705 - Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) Phase 1/Phase 2
Withdrawn NCT01936194 - The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis N/A
Recruiting NCT01692093 - KM110329 in Adult Patients With Atopic Dermatitis Phase 2
Terminated NCT01447758 - Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. Phase 1
Completed NCT01223222 - A Study to Evaluate Safety, Tolerability and Efficacy of Lytixarâ„¢ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection Phase 2
Completed NCT01179880 - A Study of E6005 in Japanese Patients With Atopic Dermatitis Phase 1/Phase 2